Pushing cancer cells to commit suicide: Is 072RB, the new BH3 mimetic, up to the job?

Cell Cycle

Volumn 7, Issue 20, 2008, Pages 3111-

  Darzynkiewicz, Zbigniew ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BH3 PROTEIN; BIM PROTEIN; CYTOCHROME C; O72RB; OBLIMERSEN; PROTEIN BCL 2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; B CELL LYMPHOMA; CANCER CELL; CANCER MODEL; CELL DEATH; DRUG DISTRIBUTION; DRUG EFFECT; DRUG STABILITY; ENZYME RELEASE; HUMAN; MITOCHONDRIAL MEMBRANE; NEOPLASM; NONHUMAN; NOTE;

EID: 54049134782     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.20.7063     Document Type: Note

References (6)

1. Gorczyca W, at al. Leukemia 1993; 7:659-70.
2. Fletcher JI, et al. Cell Cycle 2008; 7:39-44.
3. Labi V, et al. Cell Death Differ 2008; 15:977-87.
4. Wade et al., Cell Cycle 2008; 7:1973-82.
5. Konoplewa M, et al. Cancer Cell 2006; 10:375-88.
6. Ponassi R, et al. Cell Cycle 2008; In this issue.